Randomized clinical trial: 7‐day vonoprazan‐based versus 14‐day omeprazole‐based triple therapy for Helicobacter pylori

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan

(2019) Mitsushige Sugimoto et al.   Frontiers in Pharmacology

Helicobacter pylorieradication treatment and the risk of gastric adenocarcinoma in a Western population

(2018) Eva Doorakkers et al.   GUT

Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis

(2018) Kentaro Sugano   Gastric Cancer

Epidemiology of Helicobacter pylori infection

(2018) Olga Sjomina et al.   HELICOBACTER

Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

(2017) James K.Y. Hooi et al.   GASTROENTEROLOGY

Helicobacter pylori infection and nonmalignant diseases

(2017) Olga Sjomina et al.   HELICOBACTER

Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-LineHelicobacter pyloriEradication: A Randomized Controlled Trial

(2017) Masafumi Maruyama et al.   Canadian Journal of Gastroenterology and Hepatology

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype

(2016) T. Kagami et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Analysis of the cost-effectiveness of using vonoprazan–amoxicillin–clarithromycin triple therapy for first-line Helicobacter pylori eradication

(2016) Yusaku Kajihara et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

(2015) H. Jenkins et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study

(2015) Y. Sakurai et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

(2015) Yuuichi Sakurai et al.   Clinical and Translational Gastroenterology

Nationwide survey of Helicobacter pylori antibiotic resistance in Thailand

(2013) Ratha-korn Vilaichone et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE